US EditionPublished • loading... • Updated
Fapon Biopharma Publishes Pioneering Research in Cell Reports Medicine on FP008, an anti-PD 1 X IL-10M Fusion Protein for Cancer Immunotherapy
Summary by Charleston Gazette-Mail
56 Articles
56 Articles
Bennington Banner+55 Reposted by 55 other sources
Fapon Biopharma Publishes Pioneering Research in Cell Reports Medicine on FP008, an anti-PD 1 X IL-10M Fusion Protein for Cancer Immunotherapy
DONGGUAN, China, Dec. 23, 2025 /PRNewswire/ -- Fapon Biopharma, a biotech in developing therapeutic biologics including cytokine-antibody fusion proteins and T-cell engagers, announced the publication of pioneering research on FP008, a novel fusion protein in Cell Reports Medicine. The peer-reviewed…
Coverage Details
Total News Sources56
Leaning Left7Leaning Right5Center20Last UpdatedBias Distribution62% Center
Bias Distribution
- 62% of the sources are Center
62% Center
L 22%
C 62%
R 16%
Factuality
To view factuality data please Upgrade to Premium
